On 15 August 2025, Singapore’s Health Sciences Authority (HSA) issued an update listing overseas health products found to contain potent, prohibited ingredients. These may cause harmful side effects. The HSA advises consumers to avoid such products and buy only from trusted sources. Sellers in Singapore face severe penalties for supplying adulterated products. The HSA continues monitoring global enforcement to protect local consumers and urges suppliers to assess any overseas regulatory impacts.